Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis
- 31 March 2008
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 195 (1-2), 140-145
- https://doi.org/10.1016/j.jneuroim.2008.01.002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Abnormal Tr1 differentiation in multiple sclerosisJournal of Neuroimmunology, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosisJournal of Clinical Investigation, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Haplotypes within genes of β-chemokines in 17q11 are associated with multiple sclerosis: a second phase studyHuman Genetics, 2005
- Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patientsJournal of Neural Transmission, 2004
- Four Viruses, Two Bacteria, and One Receptor: Membrane Cofactor Protein (CD46) as Pathogens' MagnetJournal of Virology, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Chemokines and chemokine receptors in the pathogenesis of multiple sclerosisMultiple Sclerosis Journal, 2000
- Mechanism of Suppression of Cell-Mediated Immunity by Measles VirusScience, 1996